Jayson Cormier
About Jayson Cormier
Jayson Cormier is a Health System Specialist with extensive experience in the healthcare industry, having held various leadership roles at companies such as Takeda, Baxter International, and Pfizer. He specializes in population health management and has a strong background in strategic concept development, particularly in the rare disease and biologic sectors.
Current Role at Verrica Pharmaceuticals
Jayson Cormier currently serves as a Health System Specialist at Verrica Pharmaceuticals. He has been in this role since 2023, focusing on the Western United States. His responsibilities include enhancing product adoption and market penetration through strategic initiatives.
Previous Experience in Healthcare
Jayson Cormier has extensive experience in the healthcare sector. He worked at Takeda in various capacities, including Director of Integrated Health Systems from 2018 to 2022 and Director of National Accounts, IDN and Strategic Accounts from 2015 to 2018. He also held the position of Key Account Manager at Baxter International Inc. from 2013 to 2015 and served as a Territory Manager at Pfizer from 2002 to 2004.
Education and Expertise
Jayson Cormier studied at San Diego State University, where he earned a Bachelor of Arts and Bachelor of Sciences in International Business with a focus on Marketing, Spanish, and Western Europe from 1997 to 2000. He also attended Hawaii Pacific University, studying Marketing from 1995 to 1996. Additionally, he has been studying Spanish at La Escuela de Idiomas since 1998.
Specialization in Population Health Management
Jayson Cormier specializes in population health management, aiming to improve health outcomes across diverse patient populations. He possesses expertise in clinical and economic impact modeling, which supports decision-making processes for health systems. His experience includes creating and implementing pull-through programs.
Executive-Level Engagement
Jayson Cormier is experienced in delivering executive-level presentations and engaging with board and C-suite executives. His background includes strategic concept development and execution, particularly in the rare disease and biologic sectors, which enhances his ability to drive strategic initiatives.